US Patent Issued to SAREPTA THERAPEUTICS, Massachusetts Institute of Technology on Dec. 23 for "Bicyclic peptide oligonucleotide conjugates" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,432, issued on Dec. 23, was assigned to SAREPTA THERAPEUTICS INC. (Cambridge, Mass.) and Massachusetts Institute of Technology (Cambridge, Mass.).

"Bicyclic peptide oligonucleotide conjugates" was invented by Justin M. Wolfe (Cambridge, Mass.), Colin M. Fadzen (Cambridge, Mass.), Rebecca L. Holden (Cambridge, Mass.), Monica Yao (Cambridge, Mass.), Gunnar J. Hanson (Cambridge, Mass.) and Bradley L. Pentelute (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are oligonucleotides, bicyclic peptides, and peptide-oligonucleotide-conjugates. Also provided herein are methods of treating a muscle disease, a viral infection, or...